Brendan O'Sullivan

NF-κB as a therapeutic target in autoimmune disease

Angus Thompson, A. Thompson, Ranjeny Thomas, 2007, Expert opinion on therapeutic targets.

Abnormal NF-κB Function Characterizes Human Type 1 Diabetes Dendritic Cells and Monocytes1

Z. Mollah, J. Prins, J. Cardinal, 2008, The Journal of Immunology.